Published in Biochim Biophys Acta on February 14, 2001
Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation. Chem Res Toxicol (2009) 1.68
Acrolein, a toxicant in cigarette smoke, causes oxidative damage and mitochondrial dysfunction in RPE cells: protection by (R)-alpha-lipoic acid. Invest Ophthalmol Vis Sci (2007) 1.24
Molecular mechanisms of the conjugated alpha,beta-unsaturated carbonyl derivatives: relevance to neurotoxicity and neurodegenerative diseases. Toxicol Sci (2007) 1.15
Acrolein-mediated injury in nervous system trauma and diseases. Mol Nutr Food Res (2011) 1.05
Lipid peroxidation-derived reactive aldehydes directly and differentially impair spinal cord and brain mitochondrial function. J Neurotrauma (2010) 0.98
Interaction of aldehydes derived from lipid peroxidation and membrane proteins. Front Physiol (2013) 0.97
Hydroxytyrosol protects retinal pigment epithelial cells from acrolein-induced oxidative stress and mitochondrial dysfunction. J Neurochem (2007) 0.94
Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heart. Clin Exp Pharmacol Physiol (2012) 0.94
Neuroprotective role of hydralazine in rat spinal cord injury-attenuation of acrolein-mediated damage. J Neurochem (2013) 0.92
Molecular mechanisms of acrolein-mediated myelin destruction in CNS trauma and disease. Free Radic Res (2015) 0.89
Lipoamide protects retinal pigment epithelial cells from oxidative stress and mitochondrial dysfunction. Free Radic Biol Med (2008) 0.86
New insights in the pathogenesis of multiple sclerosis--role of acrolein in neuronal and myelin damage. Int J Mol Sci (2013) 0.85
Experimental Assessment of the Role of Acetaldehyde in Alcoholic Cardiomyopathy. Biol Proced Online (2003) 0.84
Nebivolol Ameliorates Cardiac NLRP3 Inflammasome Activation in a Juvenile-Adolescent Animal Model of Diet-Induced Obesity. Sci Rep (2016) 0.76
Neuroprotective Effect of Ethanol Extract of Leaves of Malva parviflora against Amyloid-β- (Aβ-) Mediated Alzheimer's Disease. Int Sch Res Notices (2014) 0.75
Synaptic Mitochondria Sustain More Damage than Non-Synaptic Mitochondria after Traumatic Brain Injury and Are Protected by Cyclosporine A. J Neurotrauma (2016) 0.75
trans,trans-2,4-decadienal induces mitochondrial dysfunction and oxidative stress. J Bioenerg Biomembr (2008) 0.75
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study. Neurology (2007) 4.24
Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology (2007) 3.67
Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am J Pathol (1999) 2.31
Neural transplantation in Huntington disease: long-term grafts in two patients. Neurology (2007) 2.15
Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem (1998) 1.71
Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy. J Neuropathol Exp Neurol (2000) 1.63
Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology (2005) 1.56
A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology. Brain (2007) 1.40
The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin. J Neurochem (1999) 1.32
Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease. Am J Pathol (2001) 1.26
Proteasomal inhibition induced by manganese ethylene-bis-dithiocarbamate: relevance to Parkinson's disease. Neuroscience (2004) 1.17
Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. Am J Pathol (1997) 1.16
4-Hydroxy-2(E)-nonenal inhibits CNS mitochondrial respiration at multiple sites. J Neurochem (1999) 1.12
Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid. Biochemistry (2000) 1.09
Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons. Virology (2000) 1.09
Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques. Neurology (2010) 1.07
Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase. J Neuropathol Exp Neurol (2000) 1.06
Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype. J Neuropathol Exp Neurol (1998) 1.02
Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F(2t)-Isoprostane (8-iso-PGF(2alpha)) by a stable isotope dilution mass spectrometric assay. Clin Chim Acta (2001) 0.95
4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease. J Neuropathol Exp Neurol (1997) 0.95
Massive pulmonary embolus and anabolic steroid abuse. JAMA (1992) 0.94
Selective dendritic degeneration of medium spiny neurons in dementia with Lewy bodies. Neurology (2006) 0.93
Lack of cerebral bmaa in human cerebral cortex. Neurology (2009) 0.93
Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor. Exp Neurol (2009) 0.92
Formation of highly reactive gamma-ketoaldehydes (neuroketals) as products of the neuroprostane pathway. J Biol Chem (2001) 0.89
No difference in plasma or urinary F2-isoprostanes among patients with Huntington's disease or Alzheimer's disease and controls. Ann Neurol (2000) 0.89
Lipoproteins and lipid peroxidation in Alzheimer's disease. J Nutr Health Aging (2003) 0.89
Expression and activities of aldo-keto oxidoreductases in Alzheimer disease. J Neuropathol Exp Neurol (2001) 0.88
Elevation of AKR7A2 (succinic semialdehyde reductase) in neurodegenerative disease. Brain Res (2001) 0.86
Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo. Lipids (1999) 0.85
Enhancement of dopaminergic neurotoxicity by the mercapturate of dopamine: relevance to Parkinson's disease. J Neurochem (2000) 0.85
A valid experimental brain death organ donor model. J Heart Lung Transplant (1995) 0.83
Neuronal migration disorders: positron emission tomography correlations. Ann Neurol (1994) 0.83
Reactions of 4-hydroxy-2(E)-nonenal and related aldehydes with proteins studied by carbon-13 nuclear magnetic resonance spectroscopy. Chem Res Toxicol (1998) 0.82
Fragile X gene premutation in multiple system atrophy. J Neurol Sci (2004) 0.82
Secondary excitotoxicity contributes to dopamine-induced apoptosis of dopaminergic neuronal cultures. Biochem Biophys Res Commun (1998) 0.82
High-pressure liquid chromatography quantitation of cytochrome c using 393 nm detection. Anal Biochem (1999) 0.82
Wernicke's encephalopathy in a patient with AIDS. AIDS (1993) 0.81
Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins. J Lipid Res (1998) 0.81
Expression of glutathione-S-transferase isozyme in the SY5Y neuroblastoma cell line increases resistance to oxidative stress. Free Radic Biol Med (2001) 0.80
The mitochondrial common deletion in Parkinson's disease and related movement disorders. Parkinsonism Relat Disord (2002) 0.78
Human, but not bovine, oxidized cerebral spinal fluid lipoproteins disrupt neuronal microtubules. Lipids (2000) 0.78
Dopamine thioethers in neurodegeneration. Curr Top Med Chem (2001) 0.78
Alpha-methylserotonin, a substitute transmitter for serotonergic neurons. Prog Neuropsychopharmacol Biol Psychiatry (1990) 0.77
Quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease. Adv Exp Med Biol (2001) 0.77
Interactions between apolipoprotein E gene and dietary alpha-tocopherol influence cerebral oxidative damage in aged mice. J Neurosci (2001) 0.77
Cerebrospinal fluid lipoproteins in Alzheimer's disease. Microsc Res Tech (2000) 0.76
CSF lipoproteins and Alzheimer's disease. J Nutr Health Aging (2002) 0.76
Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology (2000) 0.76
Pathologic assessment of cerebellar atrophy following acute lithium intoxication. Clin Neuropathol (1997) 0.76
Congeners of N(alpha)-acetyl-L-cysteine but not aminoguanidine act as neuroprotectants from the lipid peroxidation product 4-hydroxy-2-nonenal. Free Radic Biol Med (2000) 0.76
Cysteine and mercapturate conjugates of oxidized dopamine are in human striatum but only the cysteine conjugate impedes dopamine trafficking in vitro and in vivo. J Neurochem (2001) 0.75
Formation of novel isoprostane-like compounds from docosahexaenoic acid. Adv Exp Med Biol (1999) 0.75
High-dose cisplatin with diethyldithiocarbamate (DDTC) rescue therapy: preliminary pharmacologic observations. Cancer Chemother Pharmacol (1989) 0.75
Renal toxicity of antineoplastic agents. Toxicol Lett (1990) 0.75
Endogenous catechol thioethers may be pro-oxidant or antioxidant. Free Radic Biol Med (1999) 0.75
Divergence of brain prostaglandin H synthase activity and oxidative damage in mice with encephalitis. J Neuropathol Exp Neurol (1999) 0.75